(Q61920721)

English

Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer

clinical trial

Statements

A Phase 2 Study of GW786034 (Pazopanib) in Advanced Low-Grade or Intermediate-Grade Neuroendocrine Carcinoma (English)
0 references
0 references
0 references
0 references
0 references
0 references
March 2007
0 references
March 2014
0 references
52
0 references
21 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit